Olipop, the prebiotic soda brand, has secured a $50 million Series C funding round, pushing its valuation to $1.85 billion. The funding round was led by Monogram Capital Partners, with participation from celebrity investors such as Camila Cabello, Priyanka Chopra Jonas, and Nick Jonas.
A Rapid Rise in the Functional Beverage Market
Founded in 2018 by Ben Goodwin and David Lester, Olipop has rapidly gained traction in the health-conscious beverage space. Its sodas, which contain prebiotic fibers to promote gut health, have resonated with consumers looking for alternatives to traditional soft drinks. The brand is now stocked in over 50,000 stores across the U.S. and reported profitability in early 2025.
Olipop has seen strong investor interest in previous rounds as well. In 2021, the company raised $10 million in a Series A funding round, followed by a $30 million Series B in 2022, which included investors like Gwyneth Paltrow and the founders of RXBAR.
The Big Players Are Watching
Olipop’s rapid rise hasn’t gone unnoticed by major beverage companies. Coca-Cola, for instance, recently introduced its own prebiotic soda line, Simply Pop, signaling its intent to compete in the growing functional beverage category. While Coca-Cola hasn’t directly commented on Olipop’s latest funding round, industry experts believe the beverage giant is closely monitoring the brand’s trajectory.
With Olipop proving that consumers are willing to pay a premium for health-focused sodas, the question remains: Will the major soft drink brands continue to innovate in the prebiotic space, or will they eventually seek to acquire brands like Olipop?